1-4 of 4
Lisa E. Brodersen, PhD
Close
Sort by
Journal Articles

Revised Risk Stratification Criteria for Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Todd M Cooper, DO, Rhonda E. Ries, MA, Todd A Alonzo, PhD, Robert B Gerbing, Michael R. Loken, PhD, Lisa E. Brodersen, PhD, Susana C. Raimondi, PhD, Betsy A Hirsch, PhD, Richard Aplenc, MD, Alan S Gamis, MD MPH, Edward A Kolb, MD, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 407.
https://doi.org/10.1182/blood.V130.Suppl_1.407.407
Published: 2017
Journal Articles

Prolonged Azacitidine Exposure Alters Immunophenotype in Myeloid Leukemia Cell Lines

Allison Kaeding, MD, Laura Pardo, Michael R. Loken, PhD, Lisa E. Brodersen, PhD, Katherine Tarlock, MD, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2619.
https://doi.org/10.1182/blood.V130.Suppl_1.2619.2619
Published: 2017
Journal Articles

Clinical Implications of Detection and Clearance of Post-Induction Residual Disease in 2119 Children and Young Adults with AML: Children's Oncology Group Studies AAML0531 and AAML1031

Lisa E. Brodersen, PhD, Todd A Alonzo, PhD, Robert B Gerbing, Anders Kolb, MD, Alan S Gamis, MD MPH, Richard Aplenc, MD, Soheil Meshinchi, MD PhD, Michael R. Loken, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3905.
https://doi.org/10.1182/blood.V130.Suppl_1.3905.3905
Published: 2017
Journal Articles

Transcriptomic and Network Signatures of Cryptic Fusion CBFA2T3-GLIS2 in Pediatric AML Reveals Clinical Considerations and Implications

Jenny L. Smith, MSc, MD, Rhonda E. Ries, MA, Heather Louise Schuback, MD, Lisa E. Brodersen, PhD, Michael R. Loken, PhD, Hamid Bolouri, PhD, Soheil Meshinchi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1193.
https://doi.org/10.1182/blood.V130.Suppl_1.1193.1193
Published: 2017